FMR LLC
Institutional investor · Portfolio as of Q1 2024
Top Holdings5,353 positions
NVIDIA CORP | 115.1M | $104B | 7.0% | — | — | — | Decreased 0 |
MICROSOFT CORP | 220.9M | $92.9B | 6.2% | — | — | — | Increased 62 |
FACEBOOK INC-CLASS A | 136.8M | $66.4B | 4.5% | — | — | — | Increased 60 |
AMAZON.COM INC | 325.1M | $58.6B | 3.9% | — | — | — | Increased 60 |
APPLE INC | 289M | $49.6B | 3.3% | — | — | — | Decreased 0 |
ALPHABET INC-CL A | 226.3M | $34.2B | 2.3% | — | — | — | Decreased 0 |
ELI LILLY & CO | 34.1M | $26.5B | 1.8% | — | — | — | Increased 52 |
BERKSHIRE HATHAWAY INC-CL A | 33,428 | $21.2B | 1.4% | — | — | — | Unchanged 0 |
UNITEDHEALTH GROUP INC | 35.7M | $17.6B | 1.2% | — | — | — | Decreased 0 |
EXXON MOBIL CORP | 142.7M | $16.6B | 1.1% | — | — | — | Decreased 0 |
ALPHABET INC-CL C | 108.6M | $16.5B | 1.1% | — | — | — | Decreased 0 |
VISA INC-CLASS A SHARES | 53.1M | $14.8B | 1.0% | — | — | — | Increased 46 |
NETFLIX INC | 21M | $12.8B | 0.9% | — | — | — | Decreased 0 |
GENERAL ELECTRIC CO | 69.1M | $12.1B | 0.8% | — | — | — | Increased 47 |
SALESFORCE.COM INC | 36.9M | $11.1B | 0.7% | — | — | — | Increased 46 |
JPMORGAN CHASE & CO | 55.4M | $11.1B | 0.7% | — | — | — | Increased 47 |
WELLS FARGO & CO | 186.8M | $10.8B | 0.7% | — | — | — | Increased 47 |
REGENERON PHARMACEUTICALS | 10.8M | $10.4B | 0.7% | — | — | — | Increased 47 |
MASTERCARD INC - A | 20.8M | $10B | 0.7% | — | — | — | Increased 45 |
BOSTON SCIENTIFIC CORP | 141.9M | $9.7B | 0.7% | — | — | — | Increased 46 |
FMR LLC manages $1.5T across 5353 positions as of Q1 2024. Top holdings: NVDA (7.0%), MSFT (6.2%), META (4.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 480 new positions, 556 exits, 2686 increased. Top move: MSFT (INCREASED, conviction 62). Portfolio: $1.5T across 5353 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR